Tokyo Tape
Sign in
← Hokuyaku Takeyama Holdings

Quarterly report · Q3

3055.TEDINET S100SUQB
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥209.2bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥262.6bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥199.1bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥2.4bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥2.7bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥2.9bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥3.9bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥3.2bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥2.9bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥3.6bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥1.8bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.4bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥1.8bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥2.4bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥151.9bnat 2023-12-31Cons.Assets
Total assets¥137.9bnat 2023-03-31Cons.Assets
Total assets¥146.6bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥92.6bnat 2023-12-31Cons.Liabilities
Total liabilities¥80.5bnat 2023-03-31Cons.Liabilities
Net assets / equity¥59.3bnat 2023-12-31Cons.Net assets
Net assets / equity¥57.4bnat 2023-03-31Cons.Net assets
Net assets / equity¥57.6bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥19.5bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥18.0bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥19.5bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥18.0bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥21.4bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥21.1bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥4.5bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥828m2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥2.0bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥2.2bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.4bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥856m2022-04-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥865m2023-04-01 → 2023-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥835m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥808m2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥82.92023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥49.92023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥123.412022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥109.942022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥46.722022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio39.0%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio41.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.3%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 56
SegmentItemPeriodValue
Otherother segmentsrevenue2023-04-01 → 2023-12-31¥1.6bn
Otherother segmentsrevenue external2023-04-01 → 2023-12-31¥44m
Otherother segmentsrevenue intersegment2023-04-01 → 2023-12-31¥1.5bn
Otherother segmentssegment profit2023-04-01 → 2023-12-31¥516m
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue2023-04-01 → 2023-12-31¥10.1bn
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue external2023-04-01 → 2023-12-31¥10.1bn
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥9m
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentsegment profit2023-04-01 → 2023-12-31¥113m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue2023-04-01 → 2023-12-31¥1.2bn
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue external2023-04-01 → 2023-12-31¥369m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥794m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentsegment profit2023-04-01 → 2023-12-31¥48m
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue2023-04-01 → 2023-12-31¥49.0bn
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue external2023-04-01 → 2023-12-31¥48.6bn
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥401m
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentsegment profit2023-04-01 → 2023-12-31¥911m
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue2023-04-01 → 2023-12-31¥3.1bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue external2023-04-01 → 2023-12-31¥3.1bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥3m
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentsegment profit2023-04-01 → 2023-12-31¥217m
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue2023-04-01 → 2023-12-31¥153.6bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue external2023-04-01 → 2023-12-31¥146.9bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥6.7bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentsegment profit2023-04-01 → 2023-12-31¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥218.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥209.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥9.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥3.1bn
Otherother segmentsrevenue2022-04-01 → 2022-12-31¥1.9bn
Otherother segmentsrevenue external2022-04-01 → 2022-12-31¥46m
Otherother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥1.8bn
Otherother segmentssegment profit2022-04-01 → 2022-12-31¥819m
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥10.2bn
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥10.2bn
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥9m
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentsegment profit2022-04-01 → 2022-12-31−¥14m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥1.2bn
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥362m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥825m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentsegment profit2022-04-01 → 2022-12-31¥25m
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥49.2bn
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥48.9bn
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥379m
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥3.0bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥3.0bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥2m
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentsegment profit2022-04-01 → 2022-12-31¥295m
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥143.5bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥136.6bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥6.9bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥209.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥199.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥9.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥3.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 517
ItemContextValueUnit
Noncurrent liabilitiesPrior1YearInstant2910000000JPY
Noncurrent liabilitiesCurrentQuarterInstant3520000000JPY
LiabilitiesPrior1YearInstant80494000000JPY
LiabilitiesCurrentQuarterInstant92576000000JPY
Capital stockPrior1YearInstant1000000000JPY
Capital stockCurrentQuarterInstant1000000000JPY
Capital surplusPrior1YearInstant11821000000JPY
Capital surplusCurrentQuarterInstant11821000000JPY
Retained earningsPrior1YearInstant41315000000JPY
Retained earningsCurrentQuarterInstant42600000000JPY
Treasury stockPrior1YearInstant-1709000000JPY
Treasury stockCurrentQuarterInstant-2029000000JPY
Shareholders equityPrior1YearInstant52428000000JPY
Shareholders equityCurrentQuarterInstant53392000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant5839000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant6687000000JPY
Revaluation reserve for landPrior1YearInstant-742000000JPY
Revaluation reserve for landCurrentQuarterInstant-711000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-95000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-80000000JPY
Valuation and translation adjustmentsPrior1YearInstant5001000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant5894000000JPY
Non controlling interestsPrior1YearInstant13000000JPY
Non controlling interestsCurrentQuarterInstant14000000JPY
Net assetsPrior1YearInstant57443000000JPY
Net assetsCurrentQuarterInstant59301000000JPY
Liabilities and net assetsPrior1YearInstant137937000000JPY
Liabilities and net assetsCurrentQuarterInstant151878000000JPY
Net salesPrior1YTDDuration199071000000JPY
Net salesCurrentYTDDuration209163000000JPY
Cost of salesPrior1YTDDuration183633000000JPY
Cost of salesCurrentYTDDuration193506000000JPY
Gross profitPrior1YTDDuration15438000000JPY
Gross profitCurrentYTDDuration15656000000JPY
Packing and transportation expenses sgaPrior1YTDDuration806000000JPY
Packing and transportation expenses sgaCurrentYTDDuration867000000JPY
Salaries and allowances sgaPrior1YTDDuration6608000000JPY
Salaries and allowances sgaCurrentYTDDuration6691000000JPY
Provision for bonuses sgaPrior1YTDDuration516000000JPY
Provision for bonuses sgaCurrentYTDDuration568000000JPY
Provision for directors bonuses sgaPrior1YTDDuration83000000JPY
Provision for directors bonuses sgaCurrentYTDDuration89000000JPY
Retirement benefit expenses sgaPrior1YTDDuration265000000JPY
Retirement benefit expenses sgaCurrentYTDDuration278000000JPY
Legal welfare expenses sgaPrior1YTDDuration1085000000JPY
Legal welfare expenses sgaCurrentYTDDuration1121000000JPY
Rent expenses sgaPrior1YTDDuration218000000JPY
Rent expenses sgaCurrentYTDDuration213000000JPY
Provision of allowance for doubtful accounts sgaPrior1YTDDuration－JPY
Provision of allowance for doubtful accounts sgaCurrentYTDDuration6000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass